NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera Appear on Fox News Radio’s The Brian Kilmeade Show to Discuss PainShield’s Advantages and Potential to Reduce Opioid Use

ELMSFORD, NY–(Marketwired – March 21, 2018) – NanoVibronix Inc. (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix and former Yankees pitcher Mariano Rivera were featured guests on Fox News Radio’s The Brian Kilmeade Show to discuss PainShield’s advantages and potential to reduce opioid use. The segment can be viewed on the Fox News Radio website at:

The Company also announced that the Fox Business Network’s Mornings with Maria interview from this morning is also available online at:

Mariano Rivera is regarded within baseball as one of the most dominant relievers in major league history. His accomplishments include being named the 1999 World Series Most Valuable Player (MVP) and the 2003 AL Championship Series MVP, and he holds several postseason records. Since his retirement, he has been involved in philanthropic causes including the Mariano Rivera Foundation, a not-for-profit community-oriented foundation dedicated to making a difference in the lives of underserved children, in the U.S. and abroad. He also participated in President Trump’s Opioid and Drug Abuse Listening Session along with Governor Chris Christie and other prominent figures.

About NanoVibronix

NanoVibronix Inc. (NASDAQ: NAOV) is a medical device company headquartered in Elmsford, NY with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company’s technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home, without the assistance of medical professionals. The company’s primary products include PainShield, UroShield and WoundShield. Additional information about the company is available at:

Investor Contacts:
Crescendo Communications
[email protected]